The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation
Abstract
Inheritance of one defective copy of either of the two breast cancer susceptibility genes, BRCA1 and BRCA2, predisposes individuals to breast and ovarian cancers. Current progress in determining the function of these genes suggests that they participate in a common pathway to facilitate orderly homologous recombination and thereby maintain genomic integrity. As a consequence of this defect in homologous recombination, tumors that arise in BRCA carriers are likely to be more sensitive to ionizing radiation. This review summarizes recent investigations about the nature of the defect in DNA repair, and highlights the unanswered questions about the tumor suppressor paradox of BRCA genes. The unsolved mystery is the other genetic changes that must occur to turn a BRCA-deficient cell from a nonviable cell into a tumor cell capable of endless growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies suggest that BRCA gene mutation might influence response to radiation therapy because tumours in BRCA1/BRCA2 carriers are more sensitive to ionising radiation [5-12].”
From Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) · cites this paper as [11]
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
RetractedA Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Ford, D., Easton, D., Stratton, M. R., Narod, S., Goldgar, D., Devilee, P., Bishop, D., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · American Journal of Human Genetics · doi:10.1086/301749 · Cited by 2,766
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850 · cited 1×
“In addition to the breast cancer risk, women with BRCA1 mutations have an increased risk of ovarian cancer (Ford et al., 1994).”
BackgroundKinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D., Regel, E., Dinh, C. Q., Sands, A., Gregor Eichele, C., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,087
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,007
Research works printed but not linked: 1
- Smith PD, Crossland S, Parker G, Osin P, Brooks L, Waller J, Philp E, Crompton MR, Gusterson BA, Allday MJ and Crook T . (1999b). Oncogene, 18, 2451–2459. · DOI
Cited by
Sorted by citations
Items 301–364 of 364
The Fanconi anemia DNA maintenance pathway: focus on the FANCE and FANCF proteins
Léveillé, F. (2006) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Radiation-induced epigenome deregulation in the male germline
Tamminga, J. (2008) · Open ULeth Scholarship (OPUS) (University of Lethbridge)
p53 and DNA damage checkpoint responses in the human prostate
af Hällström, T. (2007)
Merrifield, M. (2011) · Open ULeth Scholarship (OPUS) (University of Lethbridge)
Nadkarni, A. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
DNA Repair Mechanisms in Breast Cancer Stem Cells
Yin, H., & Glass, J. (2012) · Springer eBooks · doi:10.1007/978-94-007-4590-2_6
Kupfer, G. M. (2006) · Springer eBooks · doi:10.1007/0-387-33776-8_6
DNA damage response activated by anti-cancer agent, irofulven
Wiltshire, T. D. (2007) · doi:10.33915/etd.2601
Hereditary Issues In Ovarian Cancer
Chu, C., & Rubin, S. C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-346-2_11
Palchik, G. A. (2013) · DigitalGeorgetown (Georgetown University Library)
Screening Women With Known or Suspected Cancer Gene Mutations
Phi, X.-A., Chiarelli, A. M., & de Bock, G. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802209-2.00011-5
Barbe, J. H., O’Hayer, K., & Brody, J. R. (2017) · Springer eBooks · doi:10.1007/978-1-4419-0717-2_107
Commentary EMSY links breast cancer gene 2 to the ‘Royal Family’
Yao, J., & Polyák, K. (2004)
Hollenstein, A. (2009) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-006044554
Luzhna, L. (2009) · Open ULeth Scholarship (OPUS) (University of Lethbridge)
Li, X. (2006) · OakTrust (Texas A&M University Libraries)
Reytan, S. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0347987
Hypoxia Suppresses DNA Repair: Implications for Cancer Progression and Treatment
Chan, N. H. L. (2011) · TSpace (University of Toronto)
Functional DNA repair assays with clinical and translational applications
Nadkarni, A. (2015) · RePEc: Research Papers in Economics · doi:10.21307/pdj-2015-023
Ahmed, H. (2018) · TSpace (University of Toronto)
Fundamental and clinical knowledge about breast cancer predisposition syndromes
Sugimoto, T. (2020) · Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) · doi:10.3804/jjabcs.29.1
Zhao, D., Lü, K., Liu, G., Zhu, H., Ma, L., Qi, J., & Yuan, L. (2020) · Amino Acids · doi:10.1007/s00726-020-02856-x
Evaluation of breast screening strategies in a high risk breast and ovarian cancer clinic
Knisely, A. T., Stewart, M. E., Garcia, C., Thomas, M. H., Modesitt, S. C., & Ring, K. L. (2020) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2020.100587
The latest first-line treatment options for ovarian cancer: focus on maintenance therapy
Rumyantsev, А. А. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-20-62-68
The combination strategy with epigenetic therapy, chemotherapy, and immunotherapy
Wen, S., Wang, H., & Lu, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823684-0.00013-x
Kim, B. (2020) · TSpace (University of Toronto)
Amini, M. A. (2019) · TSpace (University of Toronto)
Epigenetic Signatures of Breast Cancer Genes
Anant, S., Dhar, A., & Ramalingam, S. (2013) · Springer eBooks · doi:10.1007/978-94-007-6612-9_10
Culleton, S. P., Androphy, E. J., & Kanginakudru, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-21100-8_5
Barbe, J. H., O’Hayer, K., & Brody, J. R. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_107-1
Rumyantsev, А. А., Tyulyandina, A. S., Покатаев, И. А., Israelyan, E. R., Abramov, M. Е., Луд, А. Н., & Tyulyandin, S. А. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-9-77-83
Epigenetic therapy and DNA damage response
Baretti, M., & Azad, N. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91081-1.00009-1
Yan, J., Wu, J., Wang, Y., Di, X., Jiang, H., Wen, D., & Zhang, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2523392/v1
Self-Care: Seeking Queer Liberation from the Medical Gaze and Genetic Fatalism
Walsh, L. (2023) · AM Journal of Art and Media Studies · doi:10.25038/am.v0i28.581
Alaklabi, S., Roy, A. M., Chaudhary, L. N., & Gandhi, S. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00198
Esophageal squamous cell carcinoma in a patient with BRCA1 mutation: a rare association
Naviwala, M. S. S., Samar, M. R., Shoaib, D., Akbar, F., Idrees, R., & Rashid, Y. A. (2024) · ecancermedicalscience · doi:10.3332/ecancer.2024.1730
Ionizing Radiation as a Carcinogen
Jones, J. A., Karouia, F., Cristea, O., Somasundar, T., Popov, D., Hu, Y. F., & Welsh, J. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00106-6
Fairman, K. A. (2025) · Women s Health · doi:10.1177/17455057241307089
Exploring the Ligandability of 53BP1 through Fragment-Based Approaches
Chiew, B., Gunzburg, M. J., Foley, C. A., Zeng, H., Dong, A., Brown, P. J., The, J., Norris-Drouin, J. L., Cholensky, S. H., Mohanty, B., et al. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00125
Siri, S. O., Blasco, A. A., Moyano, G., Ahlers, M. C. M., & Gottifredi, V. (2025) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2025.108557
Introduction to breast cancer and genetic testing
Javeed, T., Jan, A., Sofi, T. A., & Mir, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27801-3.00005-3
Soghli, N., Khormali, A., & Peng, A. (2025) · Cancers · doi:10.3390/cancers17243999
Analysis of telomere maintenance in artemis defective human cell lines
Yasaei, H. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Cap a un model complet de la xarxa molecular alterada en l’anèmia de Fanconi i el càncer de mama
Sànchez, G. M. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Billaud, A., Chevalier, L.-M., Augereau, P., Frenel, J., Passot, C., Campone, M., & Morel, A. (2021) · Figshare · doi:10.6084/m9.figshare.16960210
Investigating cancer aetiology through the analysis of somatic mutation signatures
Ardin, M. (2016) · theses.fr (ABES) · doi:10.70675/c508b0eez4695z40dez83c2z943ce312732c
Stabilité du génome et rôle des INGs dans la réponse aux dommages de l'ADN
Mouche, A. (2017) · theses.fr (ABES) · doi:10.70675/2eac02ceze1a0z4c25z9effza47f3d916ad9
Impact of microbiota on intestinal stem cells survival after irradiation
Lévy, A. (2018) · theses.fr (ABES) · doi:10.70675/b6ab24a4zf5fdz489ezb1b1za2f33c2c0847
Residential Radon Levels and Ovarian Cancer Among Postmenopausal Women
Williamson, M. R., Whitsel, E. F. K. B. L., Smith, R. L., Collins, J. M., Stewart, J. D., Jung, S. Y., Harris, H. R., Feiler, M. O., Manson, J. E., Qi, L., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.8641
Functional assays for BRCA1 and BRCA2 variant analysis: new tools and their applications
Bose, M., Faseela, E. E., Rossing, M., & Sørensen, C. S. (2026) · npj Breast Cancer · doi:10.1038/s41523-026-00949-6
Sun, Z., Liang, M., Liu, X., Zhu, H., Zhang, J., Hu, P., Lin, B., Liang, X., Zhang, Z., Li, R., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9364108/v1
Sivakumar, N., & Fritz, G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.12.724504
Liu, X., Ye, S., Tian, Y., Qian, T., Jiang, W., Pei, X., & Bai, F. (2026) · Genome Instability & Disease · doi:10.1007/s42764-026-00194-y
MOLECULAR MECHANISMS OF RADIATION-INDUCED BYSTANDER EFFECTS IN VIVO
Koturbash, I. (2008) · Open ULeth Scholarship (OPUS) (University of Lethbridge)
Emerging Therapeutic Targets for Pancreatic Cancer
Shroff, R. T., & Abbruzzese, J. L. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_54
Investigation of telomere maintenance in BRCA2 defective mammalian cell lines
Chianea, Y. G. (2014) · Brunel University Research Archive (BURA) (Brunel University London)
The Role of DNA Damage and Repair in Ganciclovir-mediated Cytotoxicity.
O’Konek, J. J. (2008) · Deep Blue (University of Michigan)
Metadata
- Authors
- Powell, S. N., & Kachnic, L. A.
- Affiliations
- Massachusetts General Hospital (US)
- Boston Medical Center (US)
- Corresponding author
- Powell, Simon N
- Venue
- Oncogene
- Published
- 2003-08-28
- Volume
- 22
- Issue
- 37
- Pages
- 5784-5791
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2115808409
- Cited by
- 364
- References
- 65
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 11 · 2023: 14 · 2022: 29 · 2021: 17 · 2020: 21 · 2019: 14 · 2018: 23 · 2017: 17 · 2016: 19 · 2015: 12 · 2014: 12 · 2013: 20 · 2012: 14
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, BRCA2, homologous recombination, DNA replication fidelity, radiosensitivity, DNA repair, genome stability, breast cancer susceptibility, ovarian cancer susceptibility, tumor initiation
- MeSH terms
- DNA Replication, Humans, Neoplasms, Radiation, Ionizing, Recombination, Genetic, Apoptosis, Genes, BRCA1, Genes, BRCA2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review